Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03745339 · ClinicalTrials.gov registry record

Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

A clinical trial of Opioid-Related Disorders and Drug Addiction, sponsored by National Institute on Drug Abuse (NIDA).

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT03745339: Recruiting study of Opioid-Related Disorders and Drug Addiction, sponsored by National Institute on Drug Abuse (NIDA).

NCT03745339 is a study of Opioid-Related Disorders and Drug Addiction that is actively recruiting participants, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 150 participants, below the 344-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03745339, a study of Opioid-Related Disorders and Drug Addiction, is actively recruiting participants, sponsored by National Institute on Drug Abuse (NIDA).

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

Background: People with addictions often find it hard to choose the long-term benefits of abstinence over the short-term effects of using drugs. Researchers think this is partly due to parts of the brain involved in certain types of learning and decision-making. Researchers want to test these basic functions using a simple task with pictures and odors. Objective: To see if performance in a learning task differs between people who have opioid-use disorder and people who don t. Eligibility: Adults 21-60 years old who are willing to fast for at least 6 hours and smell food odors. Those with an opioid-use disorder must either not use for at least 3 weeks or be in treatment. Design: Participants will have 1 visit that will take up to 5 hours. Before the visit, participants will be asked to not eat or drink anything except water for at least 6 hours. At the visit, participants will be checked for signs of intoxication. Participants will give urine and breath samples. Participants will have tests of learning and behavior. They will look at shapes on a computer screen. The shapes will be paired with different food odors. The odors will come from a sterile tube placed under the nose. Participants will have their breathing monitored with a belt around the upper abdomen. About 30 days and 60 days later, participants will be called and asked about their drug use over the past 30 days.

Primary Outcome

Percentage of trials with cues A and C in which the participant predicts any odor (sweet or savory), regardless of whether the prediction is correct.

Study Locations (1)

Maryland

  • National Institute on Drug Abuse - Baltimore

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2019-06-07
Est. Completion 2026-10-01

What NCT03745339 shows while recruiting

NCT03745339 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 344-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (56% lower).

The record links to 2 conditions, with Opioid-Related Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT03745339 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03745339 about?

NCT03745339 is a clinical study titled "Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder". Background: People with addictions often find it hard to choose the long-term benefits of abstinence over the short-term effects of using drugs. Researchers think this is partly due to parts of the brain involved in certain types of learning and decision-making. Researchers want to test these basic...

What is the current status of trial NCT03745339?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2019-06-07. Estimated completion is 2026-10-01.

What conditions does trial NCT03745339 study?

This clinical trial studies the following conditions: Opioid-Related Disorders, Drug Addiction.

Who is sponsoring clinical trial NCT03745339?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03745339 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03745339's enrollment target sits among peer trials

150 21st of 47 higher than 27 of 47 other Opioid-Related Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03745339, the US trial registry maintained by the National Library of Medicine. NCT03745339 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.